Associate Vice President
Eli Lilly and Company
Dr. Datta-Mannan is currently an Associate Vice President and Clinical Team Leader in the Department of Exploratory Medicine and Pharmacology at Eli Lilly and Company. She earned her B.S. degree at McMaster University, Ontario, Canada and her Ph.D degree from Brown University and Indiana University. Dr. Datta-Mannan has ~20 years of experience as a pharmaceutical scientist leading cross-functional drug discovery and development teams in various technical and corporate leadership roles. She is passionate about enabling the progression of novel therapeutics and medicines to improve the quality of life. Along these lines, Dr. Datta-Mannan has contributed to discovery and development of multiple medicinal modalities including small molecules, monoclonal antibodies, bispecific antibodies, antibody drug conjugates, peptides and fusion proteins for autoimmunity, oncology, diabetes, migraine and musculoskeletal disorders. Dr. Datta-Mannan has key platform expertise in the area of mechanisms influencing the disposition, biodistribution and metabolism of biologics following parenteral and oral delivery. She also developed the first surrogate chemokine receptor structures to dissect the structure-function relationship of receptor-ligand interactions for developing therapies directed at autoimmune disorders. Dr. Datta-Mannan has contributed to multiple patents, published over 50 peer reviewed manuscripts and abstracts, including invited scientific reviews and pharmaceutical industry whitepaper guidance documents for biologics as a member of the IQ Consortia, presented/chaired over 30 invited oral presentations and serves on the editorial/review board of several journals.